Oral TNF alpha inhibitor in mdx dystrophic mice: a pilot Trial (2009)
Source: Neuromuscular Disorders. Conference titles: International Congress of the World Muscle Society. Unidade: ICB
Subjects: FARMACOLOGIA, FISIOLOGIA
ABNT
FEDER, D. et al. Oral TNF alpha inhibitor in mdx dystrophic mice: a pilot Trial. Neuromuscular Disorders. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 12 out. 2024. , 2009APA
Feder, D., Brito, L. H., Saad, L. S., Oliveira, V., Barros, E. A. C., dos Santos, R. A., et al. (2009). Oral TNF alpha inhibitor in mdx dystrophic mice: a pilot Trial. Neuromuscular Disorders. Oxford: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Feder D, Brito LH, Saad LS, Oliveira V, Barros EAC, dos Santos RA, Ferreira LG, Carvalho MHC de, Nunes MT, Zyngier SB, Carvalho AAS. Oral TNF alpha inhibitor in mdx dystrophic mice: a pilot Trial. Neuromuscular Disorders. 2009 ; 19( 8/9):[citado 2024 out. 12 ]Vancouver
Feder D, Brito LH, Saad LS, Oliveira V, Barros EAC, dos Santos RA, Ferreira LG, Carvalho MHC de, Nunes MT, Zyngier SB, Carvalho AAS. Oral TNF alpha inhibitor in mdx dystrophic mice: a pilot Trial. Neuromuscular Disorders. 2009 ; 19( 8/9):[citado 2024 out. 12 ]